Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | GFER | P55789 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | IL1B | P01584 | 1/20 | 0.32 |
| ▸ | IKBKB | O14920 | 1/20 | 0.31 |
| ▸ | RARA | P10276 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4607854 | 0.85 | KMT2A (0.39) | MEN1POLBGAAGFERKMT2A | |
| SCHEMBL4953880 | 0.85 | LMNA (0.42) | MEN1POLBGAAGFERKMT2A | |
| SCHEMBL4954586 | 0.82 | MEN1 (0.46) | MEN1POLBGAAGFERKMT2A | |
| SCHEMBL4953194 | 0.81 | — | — | |
| SCHEMBL4949937 | 0.79 | MEN1 (0.33) | MEN1POLBGAAGFERKMT2A | |
| SCHEMBL4950312 | 0.77 | POLB (0.32) | MEN1POLBGAAGFERKMT2A | |
| SCHEMBL27448235 | 0.76 | MEN1 (0.44) | MEN1POLBGAAGFERKMT2A | |
| SCHEMBL6760923 | 0.76 | ALDH1A1 (0.39) | MEN1POLBGAAGFERKMT2A | |
| SCHEMBL27416248 | 0.76 | LMNA (0.45) | MEN1POLBGAAGFERKMT2A | |
| SCHEMBL4955968 | 0.74 | PGR (0.33) | MEN1POLBGAAGFERKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7862981-B2 | Compound, positive resist composition and method of forming resist pattern | TOKYO OHKA KOGYO CO., LTD. (JP) | 2011-01-04 | — | — | US | disclosed |
| US-20100009284-A1 | COMPOUND, POSITIVE RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN | TOKYO OHKA KOGYO CO., LTD. (JP) | 2010-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100009284-A1 | COMPOUND, POSITIVE RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN | MRPS27, PSMC2, PSMD7 | MEN1 3250/4885POLB 296/4885GAA 2709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.